SCHEMBL2913040

SCHEMBL2913040

O=C(NC1CCCCC1)C(C1CCCCC1)C1(C(O)c2ccccc2)Nc2cc(F)c(F)cc2N1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.44
GAA P10253 2/20 0.41
NPSR1 Q6W5P4 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
C3AR1 Q16581 3/20 0.41
KMT2A Q03164 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C19 P33261 1/20 0.41
EPHX1 P07099 2/20 0.40
LMNA P02545 1/20 0.40
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 2/20 0.40
TP53 P04637 1/20 0.39
CCR1 P32246 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912425 0.93 TSHR (0.40) TSHRGAANPSR1SMN1; SMN2C3AR1
SCHEMBL2915021 0.90 KCNH2 (0.44) TSHRSMN1; SMN2NPC1RAB9ACYP3A4
SCHEMBL2907592 0.89 NPC1 (0.42) TSHRSMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL2909615 0.88 C3AR1 (0.43) TSHRSMN1; SMN2C3AR1CYP3A4CYP2C19
SCHEMBL2910028 0.86 SMN1; SMN2 (0.45) TSHRGAANPSR1SMN1; SMN2C3AR1
SCHEMBL2915028 0.85 KMT2A (0.43) GAASMN1; SMN2C3AR1KMT2ANPC1
SCHEMBL2306977 0.84 NR1H4 (0.43) SMN1; SMN2C3AR1KMT2ANPC1RAB9A
SCHEMBL2906901 0.82 CNR1 (0.40) TSHRSMN1; SMN2KMT2ANPC1RAB9A
SCHEMBL2912405 0.81 ALDH1A1 (0.40) TSHRSMN1; SMN2NPC1RAB9ACYP3A4
SCHEMBL2915018 0.81 SMN1; SMN2 (0.41) TSHRGAANPSR1SMN1; SMN2C3AR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP claimed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO claimed
EP-2222645-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. Hoffmann-La Roche AG (CH) 2010-09-01 EP disclosed
WO-2009062874-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS FXR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-05-22 WO disclosed